Key Points
- Liquidia director Arthur Kirsch sold 15,000 shares on June 1 at an average price of $60.22, totaling about $903,300. The sale cut his ownership by 50%, leaving him with 15,000 shares.
- The company recently beat earnings expectations, reporting $0.52 EPS versus the $0.41 consensus and revenue of $132.87 million, well above estimates. Revenue also surged 4,187.1% year over year.
- Analyst sentiment remains mostly positive, with several firms maintaining buy or overweight ratings and an average target price of $50.88. Liquidia shares opened at $55.53, near the high end of their 52-week range.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Sarah Krepp sold 276 shares of the company's stock in a transaction on Monday, June 1st. The stock was sold at an average price of $60.87, for a total transaction of $16,800.12. Following the sale, the insider directly owned 146,743 shares of the company's stock, valued at approximately $8,932,246.41. This represents a 0.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Sarah Krepp also recently made the following trade(s):
- On Monday, April 13th, Sarah Krepp sold 4,557 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total transaction of $174,852.09.
Liquidia Price Performance
NASDAQ LQDA opened at $55.53 on Thursday. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The company has a fifty day simple moving average of $45.73 and a 200 day simple moving average of $39.16. The company has a market cap of $4.94 billion, a P/E ratio of 396.66 and a beta of 0.58. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $63.46.
Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. Liquidia's quarterly revenue was up 4187.1% on a year-over-year basis. On average, sell-side analysts predict that Liquidia Corporation will post 2.97 EPS for the current year.
Hedge Funds Weigh In On Liquidia
Hedge funds have recently made changes to their positions in the business. Caprock Group LLC acquired a new position in shares of Liquidia in the 3rd quarter valued at $37,114,000. Apis Capital Advisors LLC acquired a new position in shares of Liquidia in the 3rd quarter valued at $9,569,000. Farallon Capital Management LLC raised its stake in shares of Liquidia by 102.1% in the 3rd quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company's stock valued at $194,783,000 after buying an additional 4,326,876 shares in the last quarter. GSA Capital Partners LLP raised its stake in shares of Liquidia by 63.6% in the 4th quarter. GSA Capital Partners LLP now owns 63,176 shares of the company's stock valued at $2,179,000 after buying an additional 24,555 shares in the last quarter. Finally, Tudor Investment Corp ET AL acquired a new position in shares of Liquidia in the 3rd quarter valued at $1,536,000. Institutional investors and hedge funds own 64.54% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on LQDA. Needham & Company LLC increased their price target on shares of Liquidia from $54.00 to $70.00 and gave the company a "buy" rating in a report on Monday, May 11th. Lifesci Capital raised shares of Liquidia to a "strong-buy" rating in a report on Thursday, March 5th. Jefferies Financial Group reissued a "buy" rating and issued a $60.00 price target on shares of Liquidia in a report on Monday, May 11th. Oppenheimer increased their price target on shares of Liquidia from $16.00 to $19.00 and gave the company an "underperform" rating in a report on Thursday, March 12th. Finally, HC Wainwright increased their price target on shares of Liquidia from $55.00 to $67.00 and gave the company a "buy" rating in a report on Tuesday, May 12th. Three analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $50.88.
Check Out Our Latest Stock Analysis on LQDA
Liquidia Company Profile
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
